ClinicalTrials.Veeva

Menu

High Intensity Interval Training in UK Cardiac Rehabilitation Programmes (HIIT-or-MISS)

U

University Hospitals Coventry and Warwickshire NHS Trust

Status

Completed

Conditions

Coronary Disease

Treatments

Other: High intensity interval training

Study type

Interventional

Funder types

Other

Identifiers

NCT02784873
GM164715

Details and patient eligibility

About

The purpose of the trial is to compare the effects of high intensity interval training (HIIT) with usual care - moderate intensity steady state training (MISS) - in UK cardiac rehabilitation (CR) programmes.

Full description

Current cardiac rehabilitation (CR) guidelines recommend moderate intensity, steady state exercise training (MISS). However, this guideline predates significant advances in interventional and medical treatment for coronary heart disease (CHD) and may not, therefore, be the most effective strategy for the 'modern' patient with CHD. Recent research has indicated that greater benefit may be attained by participating in high intensity interval training (HIIT) which involves repeated short bursts of harder exercise interspersed with short recovery periods. Studies suggest that this can be performed without any compromise in exercise adherence or patient safety. The benefit of this approach in 'real world' CR programmes in the UK cannot be confirmed, as studies have been predominantly conducted in the laboratory and exclusively outside the UK.

In patients attending CR programmes in the UK, the investigators hypothesise that HIIT will improve VO2 peak to a greater extent than MISS. The investigators also hypothesise that HIIT will: 1) be more palatable than MISS and demonstrate greater patient compliance and adherence; 2) improve cardiovascular health to a greater extent than MISS; 3) improve HR-QoL to a greater extent than MISS; 4) lead to more positive motivation and attitudes to exercise than MISS; 5) increase short and medium-term participation in lifestyle physical activity to a greater extent than MISS; 6) be a cost effective alternative to MISS; 7) be as safe as MISS.

The HIIT or MISS study is a pragmatic single-blind, multi-centre, longitudinal, randomised controlled trial. Participants will be randomly allocated to 8 weeks of HIIT or MISS (usual care). Outcomes will be assessed at baseline, 8 weeks and 12 months by assessors blinded to group allocation. Study interventions will be delivered by clinical (not research) staff.

Enrollment

382 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

General inclusion criteria:

  1. Successfully revascularised following percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG)
  2. Angiographically documented non-obstructive coronary artery disease (CAD)
  3. Left ventricular ejection fraction (LVEF) > 40%
  4. Clinically stable (symptoms and medication) for > 2 weeks 5.18 - 75 yrs of age

General exclusion criteria:

  1. Symptoms of ischemia
  2. Significant left main stem stenosis
  3. NYHA class III-IV symptoms
  4. Compromising cardiac ventricular arrhythmia
  5. Significant valvular heart disease
  6. Inability to comply with guidelines for participation in exercise testing and training
  7. Significant limiting comorbidities that would prevent full participation

Additional exclusion criteria:

Further to the analysis of cardiopulmonary exercise test and echocardiography at baseline, and prior to randomisation, patients will be prevented from continuing their involvement in the study if there is indication of:

  1. Exercise induced ischemia or significant hemodynamic compromise
  2. LVEF < 40%
  3. Clinical instability in accordance with CR guidelines
  4. Inability to comply with guidelines for participation in exercise testing and training

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

382 participants in 2 patient groups

Usual care
No Intervention group
Description:
Usual care cardiac rehabilitation with exercise training as per current guidelines Warm up: 15 mins, \< 40% heart rate reserve (HRR) Cardiovascular component: progress towards 20 - 40 mins continuous cardiovascular exercise at 40-70% HRR. Muscular strength and endurance programme. Cool down: 10 mins, \< 40% HRR. Initial duration based on participant's previous and current physical activity (PA) levels and cardiopulmonary exercise test (CPEX) performance. Duration and workload of cardiovascular component adjusted, as tolerated, within the above parameters, in response to exercising heart rate (HR), participant reported rating of perceived exertion (RPE) and symptoms.
High intensity interval training
Experimental group
Description:
High intensity interval training within a standard cardiac rehabilitation programme. Warm up: 15 mins total, 10 mins \<40-70% HRR, 5 mins \<70% HRR. Cardiovascular component: exercise bike interval training: 10 x high @ 85-90% peak power output (PPO) from CPEX, 10 x low @ 20-25% PPO (exercise intensity will not to be prescribed from gas exchange data i.e. %VO2 peak). Change in intensity from low to high achieved by altering cadence (rpm). Muscular strength and endurance programme. Cool down: 10 mins, \<40% HRR. Duration of intervals and total programme duration increased in a standardised fashion. Workload increased bi-weekly in response to participant reported RPE (only after the full 10 x 1 protocol has been achieved). If RPE \< 17 then workload will be increased.
Treatment:
Other: High intensity interval training

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems